Next to its physiological function, PRELP has been reported as a biomarker in different human cancers, but its role is controversially discussed dependent on the tumor type analyzed [33–35] regarding its correlation with the patients’ survival [34, 36] and prognostic potential [30, 36–41]. The gene discussed is PRELP; the disease is cancer.